Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma with PVTT”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Not applicableUnknownNCT02813096
What this trial is testing

Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients

Who this might be right for
Carcinoma, Hepatocellular
Guangxi Medical University 500
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Not applicableUnknownNCT05339581
What this trial is testing

IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation

Who this might be right for
Liver CancerLiver Transplant; ComplicationsHepatocellular Carcinoma+2 more
RenJi Hospital 78
Large-scale testing (Phase 3)UnknownNCT04387695
What this trial is testing

SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT

Who this might be right for
Unresectable Hepatocellular CarcinomaPortal Vein Thrombosis
First Affiliated Hospital of Zhejiang University 54
Not applicableUnknownNCT05530785
What this trial is testing

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Yongchang Zhang 35
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Large-scale testing (Phase 3)Active Not RecruitingNCT04649489
What this trial is testing

Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev

Who this might be right for
Venous Thrombosis
Jia Fan 501
Testing effectiveness (Phase 2)Looking for participantsNCT06646198
What this trial is testing

TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension

Who this might be right for
Hepatocellular Carcinoma with PVTT
Fei Gao 40
Post-approval studies (Phase 4)UnknownNCT01350206
What this trial is testing

Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With PVTT
Sun Yat-sen University 180
Large-scale testing (Phase 3)UnknownNCT02301091
What this trial is testing

Combine TACE and RFA Versus TACE Alone for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Ming Zhao 240
Not applicableUnknownNCT04619342
What this trial is testing

Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)

Who this might be right for
Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)
Beijing Tsinghua Chang Gung Hospital 98
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Testing effectiveness (Phase 2)Looking for participantsNCT07327788
What this trial is testing

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

Who this might be right for
Hepatecellular CarcinomaRALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and OxaliplatinBevacizumab+3 more
Nanfang Hospital, Southern Medical University 38
Testing effectiveness (Phase 2)UnknownNCT04850157
What this trial is testing

Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 30
Not applicableUnknownNCT04181931
What this trial is testing

Neo-TACE-HAIC for PVTT-HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Sun Yat-sen University 320
Large-scale testing (Phase 3)Looking for participantsNCT03368651
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 230
Not applicableStudy completedNCT03108248
What this trial is testing

ISP-TACE Versus TACE for HCC With PVTT

Who this might be right for
HCCPortal Vein Tumor Thrombosis
Zhongda Hospital 126
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Next Page